Filters

Filter by Speaker
02/06
18:05 - 18:50

Industry symposium - Dry Eye Disease: is there personalized treatment?
The biological role of tear substitutes

Cristian GUARISE (ITALY)

Round table - Dry Eye Disease: from diagnosis to treatment, what the challenges? Clinical cases from our experience

Elisabeth MESSMER (GERMANY), Stefano BARABINO (ITALY), Jose BENITEZ DEL CASTILLO (SPAIN)

03/06
08:30 - 09:00

Industry symposium - Dry Eye clinical trials: past, present and future!

Speakers: Doina GHERGUEL (UNITED KINGDOM), George OUSLER (UNITED STATES), Christophe BAUDOUIN (FRANCE)

With over 30 years of experience evaluating Dry Eye therapeutic approaches, Ora is delighted to share lessons learned on how to optimize Dry Eye clinical trials and product development. Insights on trial designs, endpoint selection, recruitment, and methods to reduce data variability will all be covered in this engaging discussion.

03/06
12:30 - 13:15

Industry symposium - From the eyelids to the tear film

Chairspersons: Elisabeth MESSMER (GERMANY), Christophe BAUDOUIN (FRANCE)

Examination of the eyelashes and eyelid margin

Teifi JAMES (UNITED KINGDOM)

Evaporative Dry Eye pathophysiology, the role of the lipid layer

Elisabeth MESSMER (GERMANY)

Effectiveness of lid warming in the management of meibomian gland dysfunction

Christina JACOBI (GERMANY)

Do not forget the aqueous layer

Christina GRUPCHEVA (BULGARIA)

03/06
14:15 - 15:00

Industry symposium - The European Dry Eye Disease consensus: a catalyst for change

Speakers: Elisabeth MESSMER (GERMANY), Jose BENITEZ DEL CASTILLO (SPAIN), Sajjad AHMAD (UNITED KINGDOM)

Chairperson: Christophe BAUDOUIN (FRANCE)

Patient perspectives on living with Dry Eye Disease

Welcome and introduction

Christophe BAUDOUIN (FRANCE)

A consensus to advance patient care

Implementing recommendations in clinical practice

Sajjad AHMAD (UNITED KINGDOM)

Q&A session and symposium close

03/06
15:00 - 16:00

Future developments in Dry Eye

Chairspersons: Elisabeth MESSMER (GERMANY), Christophe BAUDOUIN (FRANCE)

Companies presentations:

Ora - Unlocking Dry Eye innovation with the latest clinical technologies

George OUSLER (UNITED STATES)

Alcon - Visionary path: pioneering next generation solutions

Senol DEMIRCAN (SWITZERLAND)

Fidia - Hyaluronic acid: a rolling innovation story

Cristian GUARISE (ITALY)

Link Biologics - Harnessing intrinsic protective pathways to treat Dry Eye Disease

Caroline MILNER

Bioprotection in Dry Eye

Darine FAKIH

Oculis - The clinical efficacy and safety of topical TNF alpha inhibitor (OCS-02) in Dry Eye Disease

Bastian DEHMEL

Novaliq - Overcoming limitations of current cyclosporine Dry Eye Disease therapies

Christian ROESKY (GERMANY)

Santen - Santen’s journey on continuously advancing Dry Eye Disease care

Ioana GROBEIU

03/06
16:30 - 17:00

Industry symposium - Patient versus doctor: symptoms versus signs

Chairperson: Jose BENITEZ DEL CASTILLO (SPAIN)

Panel disccussion

James WOLFFSOHN (UNITED KINGDOM), Antonio DI ZAZZO (ITALY)